AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

West Pharmaceutical Servi... (WST)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

209.69

-5.04 (-2.35%)

At close: Feb 18, 2025, 3:59 PM

211.00

0.62%

After-hours: Feb 18, 2025, 07:49 PM EST

undefined% (undefined)

Bid	210
Market Cap	15.19B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	6.7
PE Ratio (ttm)	31.3
Forward PE	n/a
Analyst	Buy

Ask	212
Volume	1,543,011
Avg. Volume (20D)	631,432
Open	216.00
Previous Close	214.73
Day's Range	206.12 - 216.98
52-Week Range	197.01 - 400.88
Beta	undefined

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom so...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Mar 17, 1980

Employees 10,600

Stock Exchange NYSE

Ticker Symbol WST

Website https://www.westpharma.com

Full Company Profile

Analyst Forecast

According to 5 analyst ratings, the average rating for WST stock is "Buy." The 12-month stock price forecast is $372.5, which is an increase of 77.64% from the latest price.

Buy 80.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

West Pharmaceutical Services Inc. is scheduled to release its earnings on Apr 24, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

5 days ago

-38.22%

West Pharmaceutical Services shares are trading lo... Unlock content with Pro Subscription

2 months ago

+4.21%

West Pharmaceutical Services shares are trading higher after UBS upgraded the stock from Neutral to Buy and raised its price target from $350 to $390.

News

2 days ago · seekingalpha.com

West Pharmaceuticals Takes A Plunge, But May Still Offer Opportunities

The price of West Pharmaceutical Services plunged over 38% after it released its Q4 and FY 2024 earnings results on February 13. Shareholders, mostly institutional investors apparently, did not like t...

5 days ago · youtube.com

Final Trade: WST, BTC, GLD, ALT

The final trades of the day with the Fast Money traders.

4 days ago · forbes.com

Is WST Stock Undervalued At $200?

West Pharmaceutical Services, a global provider of solutions for drugs, biologics, gene therapies, and consumer healthcare products, recently announced its Q4 results, surpassing analysts' expectation...

6 days ago · seekingalpha.com

West Pharmaceutical Services, Inc. (WST) Q4 2024 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST ) Q4 2024 Earnings Conference Call February 13, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chair...

6 days ago · marketwatch.com

West Pharma's stock tanks 33% to lead S&P 500 decliners as guidance misses by a wide margin

West Pharmaceutical Services Inc.'s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for 2025 ...

5 days ago · benzinga.com

West Pharmaceutical Stock Sinks On Weaker Than Expected 2025 Guidance

On Thursday, West Pharmaceutical Services, Inc. WST reported a fourth-quarter adjusted EPS of $1.82, beating the consensus of $1.72.

5 days ago · reuters.com

West Pharmaceutical forecasts 2025 results below expectations, shares drop

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong dollar and as the medical equipment maker's clients reduce inventory levels, ...

5 days ago · zacks.com

West Pharmaceutical Services (WST) Surpasses Q4 Earnings and Revenue Estimates

West Pharmaceutical Services (WST) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.83 per share a year ago...

1 week ago · zacks.com

Will Segmental Performance Drive West Pharmaceutical's Q4 Earnings?

West Pharmaceutical Services WST is scheduled to release fourth-quarter 2024 results on Feb. 13, before the opening bell. In the last reported quarter, the company delivered an earnings beat of 22.52%...

4 weeks ago · zacks.com

Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now

WST continues to gain momentum due to its strength in the Pharma market unit. However, the decline across its Generics and Biologics business units is concerning.

Load More News